PATENT CLAIM ANALYSIS

Application Number: 16133143
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "150100"]

Abstract:
This disclosure provides antibodies that are useful for preventing and/or treating malaria. The epitope to which the antibodies bind is in close proximity to the conserved proteolytic cleavage site of  P. falciparum  circumsporozoite protein (CSP), and the antibodies provided in this disclosure can prevent cleavage and inhibit  P. falciparum  sporozoites from invading the liver.

Claim (Index 12):
The method of  claim 1 , wherein framework regions of the heavy chain are human framework regions.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 97.0
- Lexical Diversity: 1.28261
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15056458', '14097799', '15451280', '12897453', '15451268']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6945358351224182
- 35 USC 102 Novelty (BERT): 0.5540798812965184
- Combined Prediction Score: 0.6804902397398283
- Mean Citation Score: 330.43230000000005
- Max Citation Score: 461.0958
- Similarity Product: 234.4865534153223

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test